购物车
全部删除
您的购物车当前为空
别名 2-(2-tert-butylphenoxy)-N-(4-hydroxyphenyl)acetamide
NAT是一种NAMPT(nicotinamide phosphoribosyltransferase)激活剂,能够增加细胞内NAD水平并诱导随后的代谢和转录重编程,在化疗诱导的周围神经病变(CIPN)小鼠模型中具有神经保护作用,可用于研究神经退行性疾病或与NAD水平下降相关的疾病。


为众多的药物研发团队赋能,
让新药发现更简单!
NAT是一种NAMPT(nicotinamide phosphoribosyltransferase)激活剂,能够增加细胞内NAD水平并诱导随后的代谢和转录重编程,在化疗诱导的周围神经病变(CIPN)小鼠模型中具有神经保护作用,可用于研究神经退行性疾病或与NAD水平下降相关的疾病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 347 | 现货 | |
| 5 mg | ¥ 828 | 现货 | |
| 10 mg | ¥ 1,320 | 现货 | |
| 25 mg | ¥ 2,660 | 现货 | |
| 50 mg | ¥ 3,970 | 现货 | |
| 100 mg | ¥ 5,670 | 现货 | |
| 200 mg | ¥ 7,890 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 892 | 现货 |
NAT 相关产品
| 产品描述 | NAT is a nicotinamide phosphoribosyltransferase (NAMPT) activator that increases intracellular NAD levels and induces subsequent metabolic and transcriptional reprogramming. It exhibits neuroprotective effects in a chemotherapy-induced peripheral neuropathy (CIPN) mouse model and may be employed in studies of neurodegenerative diseases or conditions associated with reduced NAD levels. |
| 靶点活性 | NAMPT:5.7 μM (EC50) |
| 体外活性 | NAT(10 µM)激活NAMPT(EC50=5.7 µM),保护U2OS细胞免受FK866的毒性作用。[1] |
| 体内活性 | 在化疗诱导的周围神经病变(CIPN)小鼠模型中,NAT(30 mg/kg,腹腔注射,每日一次,持续2周)通过提升机械痛觉过敏阈值来发挥神经保护作用。[1] |
| 别名 | 2-(2-tert-butylphenoxy)-N-(4-hydroxyphenyl)acetamide |
| 分子量 | 299.36 |
| 分子式 | C18H21NO3 |
| CAS No. | 831243-31-3 |
| Smiles | O=C(NC1=CC=C(O)C=C1)COC=2C=CC=CC2C(C)(C)C |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度信息 | DMSO: ≥ 80 mg/mL, Sonication is recommended. |
评论内容